SCHEMBL31467052

SCHEMBL31467052

CC(c1ccc(Cl)cc1)N1CC2(CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)C1

nearest known ligand 0.75

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 20/20 0.75
▸ BCL2L1 Q07817 7/20 0.75
▸ CYP2C9 P11712 2/20 0.71
▸ NSD2 O96028 1/20 0.71
▸ ADORA3 P0DMS8 1/20 0.71
▸ ADRA2C P18825 1/20 0.71
▸ SLC6A2 P23975 1/20 0.71
▸ BID P55957 1/20 0.71
▸ SLC6A3 Q01959 1/20 0.71
▸ MCL1 Q07820 1/20 0.71
▸ ASPH Q12797 1/20 0.71
▸ BCL2L2 Q92843 1/20 0.71
▸ BAD Q92934 1/20 0.71
▸ NSD1 Q96L73 1/20 0.71
▸ NSD3 Q9BZ95 1/20 0.71
▸ CYP3A4 P08684 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31467034 0.95 BCL2 (0.74) BCL2BCL2L1CYP2C9NSD2ADORA3
SCHEMBL31467218 0.95 BCL2 (0.77) BCL2BCL2L1CYP2C9NSD2ADORA3
SCHEMBL31467039 0.94 BCL2 (0.74) BCL2BCL2L1CYP2C9NSD2ADORA3
SCHEMBL31467191 0.93 BCL2 (0.75) BCL2BCL2L1CYP2C9NSD2ADORA3
SCHEMBL31467026 0.87 BCL2 (0.74) BCL2BCL2L1CYP2C9NSD2ADORA3
SCHEMBL31467013 0.87 BCL2 (0.77) BCL2BCL2L1CYP2C9NSD2ADORA3
SCHEMBL31467232 0.87 BCL2 (0.76) BCL2BCL2L1
SCHEMBL24774722 0.86 BCL2 (1.00) BCL2BCL2L1CYP2C9CYP3A4
SCHEMBL30658633 0.86 BCL2 (1.00) BCL2BCL2L1CYP2C9CYP3A4
SCHEMBL20578138 0.85 BCL2 (0.77) BCL2BCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025064952-A1 BCL-2 INHIBITORS Eil Therapeutics, Inc. (US) 2025-03-27 — — WO disclosed
Send feedback